Digi Romania targets refinancing with €500 million notes

Business Forum
Digi Communications has announced a major refinancing move through its Romanian subsidiary, Digi Romania.

The company has launched an offering of €500 million in aggregate principal amount of Senior Secured Notes due in 2031.

This strategic financial operation is aimed at bolstering the company's financial structure and involves a conditional full redemption of all outstanding €400 million 3.25% senior secured notes due 2028.

The gross proceeds from the new Notes offering will be primarily used for this refinancing. Specifically, they will cover the redemption of the entire principal amount of the 2028 Notes, partially prepay Facility A under a senior facilities agreement dated April 21, 2023, and serve for general corporate purposes, including the payment of transaction costs. 

The redemption of the 2028 Notes is conditional upon the successful completion of the new financing transaction. The redemption date is presently expected to be October 30 2025, subject to possible postponement.

The new Notes, which will be Digi Romania's senior secured obligations, will be offered in minimum denominations of €100,000. The obligations will be secured by first-ranking security interests over a significant portion of Digi Romania's present and future movable assets, including bank accounts, trade receivables, and intellectual property rights, as well as all shares of Digi Spain held by Digi Romania. 

Furthermore, the security package includes certain assets of Digi Communications, notably all shares it holds in Digi Romania. The Notes are being offered to "qualified institutional buyers" and non-U.S. investors outside the US.

 

RECOMMENDED
RECOMMENDED FROM THE HOME PAGE
CCE sells major solar project in Romania
Energy

CCE sells major solar project in Romania

CMS has advised CCE on the sale of Horia Solar Invest Two, a special purpose vehicle developing a 269.227 MW (AC)/ 293.260 MWp solar project spanning more than 349 hectares in Arad County (Horia 2), to Renalfa Solarpro Group.

Industry

Life sciences M&A surges 81% as big pharma hunts for growth, says EY

Global life sciences M&A activity increased by 81% in 2025 to $240 billion, driven by Big Pharma's large-scale deals, despite fewer overall transactions. The surge reflects companies prioritising innovations ready for launch as they face widening growth gaps.

READ MORE
Business Forum  |  19 January, 2026 at 12:06 PM
Business Forum  |  19 January, 2026 at 10:14 AM